NCT02760420View on ClinicalTrials.gov

3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi

PHASE4CompletedINTERVENTIONAL
Enrollment

1,126

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

June 30, 2019

Conditions
Pneumonia
Interventions
DRUG

Amoxicillin

Oral amoxicillin dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily

DRUG

Placebo

Oral placebo dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily

Trial Locations (2)

Unknown

Bwaila District Hospital, Lilongwe

Kamuzu Central Hospital, Lilongwe

All Listed Sponsors
collaborator

University of North Carolina

OTHER

collaborator

University of Washington

OTHER

lead

Save the Children

OTHER

NCT02760420 - 3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi | Biotech Hunter | Biotech Hunter